The prognostic value of 18F-FDG PET-derived whole-body feature in patients with lung adenocarcinoma treated with EGFR-targeted therapy
- DOI
- 10.1007/s12149-025-02108-6
- Published
- 2025-09-22
- Container
- Annals of Nuclear Medicine
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s12149-025-02108-6,
title = {The prognostic value of 18F-FDG PET-derived whole-body feature in patients with lung adenocarcinoma treated with EGFR-targeted therapy},
author = {Kun-Han Lue and Yung-Hsuan Wang and Yu-Hung Chen and Sung-Chao Chu and Chih-Bin Lin and Shu-Hsin Liu},
year = {2025},
journal = {Annals of Nuclear Medicine},
doi = {10.1007/s12149-025-02108-6},
url = {https://doi.org/10.1007/s12149-025-02108-6}
}RIS
TY - JOUR TI - The prognostic value of 18F-FDG PET-derived whole-body feature in patients with lung adenocarcinoma treated with EGFR-targeted therapy AU - Kun-Han Lue AU - Yung-Hsuan Wang AU - Yu-Hung Chen AU - Sung-Chao Chu AU - Chih-Bin Lin AU - Shu-Hsin Liu PY - 2025 JO - Annals of Nuclear Medicine DO - 10.1007/s12149-025-02108-6 UR - https://doi.org/10.1007/s12149-025-02108-6 ER -
APA
Lue, K., Wang, Y., Chen, Y., Chu, S., Lin, C., & Liu, S. (2025). The prognostic value of 18F-FDG PET-derived whole-body feature in patients with lung adenocarcinoma treated with EGFR-targeted therapy. Annals of Nuclear Medicine. https://doi.org/10.1007/s12149-025-02108-6
Source records
- crossref · retrieved 2026-09-26T01:50:26.708Z